Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

Friday BB, Anderson SK, Buckner J, Yu C, Giannini C, Geoffroy F, Schwerkoske J, Mazurczak M, Gross H, Pajon E, Jaeckle K, Galanis E.

Neuro Oncol. 2012 Feb;14(2):215-21. doi: 10.1093/neuonc/nor198. Epub 2011 Nov 16.

2.

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.

Friday BB, Yu C, Dy GK, Smith PD, Wang L, Thibodeau SN, Adjei AA.

Cancer Res. 2008 Aug 1;68(15):6145-53. doi: 10.1158/0008-5472.CAN-08-1430.

3.

Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells.

Yu C, Friday BB, Yang L, Atadja P, Wigle D, Sarkaria J, Adjei AA.

Neuro Oncol. 2008 Jun;10(3):309-19. doi: 10.1215/15228517-2007-063. Epub 2008 Apr 29.

4.

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.

Friday BB, Adjei AA.

Clin Cancer Res. 2008 Jan 15;14(2):342-6. doi: 10.1158/1078-0432.CCR-07-4790.

5.

Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy.

Steensma DP, Friday BB.

Leuk Lymphoma. 2007 Aug;48(8):1628-9. No abstract available.

PMID:
17701595
6.
7.

Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways.

Yu C, Friday BB, Lai JP, Yang L, Sarkaria J, Kay NE, Carter CA, Roberts LR, Kaufmann SH, Adjei AA.

Mol Cancer Ther. 2006 Sep;5(9):2378-87.

8.

Images in cardiovascular medicine. Systemic complications of infective endocarditis.

Friday BB, Deb A.

Circulation. 2005 Nov 15;112(20):e324. No abstract available.

9.

K-ras as a target for cancer therapy.

Friday BB, Adjei AA.

Biochim Biophys Acta. 2005 Nov 25;1756(2):127-44. Epub 2005 Aug 18. Review.

PMID:
16139957
10.

Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD.

Friday BB, Mitchell PO, Kegley KM, Pavlath GK.

Differentiation. 2003 Apr;71(3):217-27.

PMID:
12694204
11.

Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway.

Horsley V, Friday BB, Matteson S, Kegley KM, Gephart J, Pavlath GK.

J Cell Biol. 2001 Apr 16;153(2):329-38.

12.
13.

Calcineurin activity is required for the initiation of skeletal muscle differentiation.

Friday BB, Horsley V, Pavlath GK.

J Cell Biol. 2000 May 1;149(3):657-66.

14.

Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells.

Abbott KL, Friday BB, Thaloor D, Murphy TJ, Pavlath GK.

Mol Biol Cell. 1998 Oct;9(10):2905-16.

15.

AM67, a secretory component of the guinea pig sperm acrosomal matrix, is related to mouse sperm protein sp56 and the complement component 4-binding proteins.

Foster JA, Friday BB, Maulit MT, Blobel C, Winfrey VP, Olson GE, Kim KS, Gerton GL.

J Biol Chem. 1997 May 9;272(19):12714-22.

16.

The sperm acrosomal matrix contains a novel member of the pentaxin family of calcium-dependent binding proteins.

Noland TD, Friday BB, Maulit MT, Gerton GL.

J Biol Chem. 1994 Dec 23;269(51):32607-14.

Supplemental Content

Loading ...
Support Center